Although hepatic mRNA expressions of CX26, CX32, and CX43 remain unchanged during the development of NAFLD and diabetes, they may still play significant roles in maintaining metabolic homeostasis by providing constitutive ATP release. Here, GJA1 is linked to metabolic dysfunction-associated steatotic liver disease.